Actuate Therapeutics, Inc. (ACTU) income statement
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.01 (-2.38%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Actuate Therapeutics, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -553.7%
Financial strength
- Current ratio
- 0.73
- Debt to equity
- -0.50
- Debt to assets
- 12.6%
- Cash to current liabilities
- 58.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?